WebApr 26, 2010 · This phase II trial is studying how well giving bendamustine hydrochloride, etoposide, dexamethasone, and filgrastim together for peripheral stem cell mobilization works in treating patients with refractory or recurrent lymphoma or multiple myeloma. Giving chemotherapy, such as bendamustine hydrochloride, etoposide, and dexamethasone, … WebMar 30, 2024 · KPS, Karnofsky Performance Scale, IPI- International Prognostic Index; R-EPOCH, rituximab-etoposide-prednisone-vincristine-cyclophosphamide-doxorubicin, R-HyperCVAD, rituximab-hyper fractionated cyclophosphamide-vincristine-doxorubicin-dexamethasone-methotrexate-cytarabine, R-DHAC-rituximab-dexamethasone …
National Center for Biotechnology Information
WebNov 16, 2007 · DCEP (dexamethasone, cyclophosphamide, etoposide, cisplatin) is a well established regimen with good efficacy as salvage treatment for myeloma. Additionally, the use of DCEP with G-CSF for mobilization in myeloma has previously been reported to provide an average yield of approximately 6x10 6 CD34 + cells. We report our … Web1 day ago · Methotrexate, etoposide, dexamethasone, pegaspargase (MESA) with sandwiched radiotherapy is known to be effective for early-stage extranodal natural-killer/T-cell lymphoma, nasal type (NKTCL). We explored the efficacy and safety of reduced-intensity, non-intravenous etoposide, dexamethasone, pegaspargase (ESA) with … can auto shapes be edited in word
Carfilzomib combined with rituximab, ifosfamide, carboplatin, and ...
Web8 weeks) and dexamethasone (initially 10 mg/m2 for 2 weeks fol-lowed by 5 mg/m 2for 2 weeks, 2.5 mg/m for 2 weeks, 1.25 mg/m2 for one week, and one week of tapering). ... rescue regimen such as HLH-94 or doxorubicin-etoposide-methylprednisolone (DEP); (2) If patients were diagnosed with lym- WebApr 12, 2024 · Methotrexate, etoposide, dexamethasone, pegaspargase (MESA) with sandwiched radiotherapy is known to be effective for early-stage extranodal natural-killer/T-cell lymphoma, nasal type (NKTCL). We explored the efficacy and safety of reduced-intensity, non-intravenous etoposide, dexamethasone, pegaspargase (ESA) with … WebDec 21, 2024 · Without treatment, the prognosis of HLH is dismal. 4 The introduction of etoposide was the first major advance in the treatment of this disease. The etoposide-based treatment protocol HLH-94 consisted of 8 weeks of induction therapy and subsequent continuation therapy until hematopoietic stem cell transplantation (HSCT) for patients … can autosweep be used in nlex